nLife Therapeutics SL-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:nLife Therapeutics SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014244
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
nLife Therapeutics SL (nLife Therapeutics) is a biopharmaceutical company that discovers and develops proprietary neuronal specific oligonucleotides as therapeutic agents for the treatment of central nervous system disorders. Its lead candidate NLF-PD-1233 is a first in class oligonucleotide treatment for Parkinson Disease. nLife Therapeutics’s delivery technology is based on the treatment of CNS disorders, chemical conjugated gene-silencing therapeutic agents and neuron-type delivery. Its other target treatment areas include Huntington disease, Alzheimer disease, DucheneDisease, neuro-inflammation, major depressive disorder and obesity among others. The company operates through laboratories located in Granada and Barcelona, Spain. nLife Therapeutics is headquartered in Armilla, Spain.

nLife Therapeutics SL – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
nLife Therapeutics SL, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
nLife Therapeutics SL, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
nLife Therapeutics SL, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
nLife Therapeutics SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
nLife Therapeutics SL, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
nLife Therapeutics SL, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
nLife Therapeutics Raises USD2.7 Million in Venture Financing 10
nLife Therapeutics Raises US$6.6 Million In Venture Financing 11
Partnerships 12
nLife Therapeutics Enters into Research Agreement with WAVE Life Sciences 12
Chemotargets Enters Into Drug Discovery Agreement With nLife Therapeutics 13
nLife Therapeutics SL – Key Competitors 14
nLife Therapeutics SL – Key Employees 15
nLife Therapeutics SL – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Corporate Communications 17
Jun 01, 2016: nLife Therapeutics appoints Dr. Errol B. De Souza as Executive Chairman 17
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
nLife Therapeutics SL, Pharmaceuticals & Healthcare, Key Facts 2
nLife Therapeutics SL, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
nLife Therapeutics SL, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
nLife Therapeutics SL, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
nLife Therapeutics SL, Deals By Therapy Area, 2011 to YTD 2017 8
nLife Therapeutics SL, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
nLife Therapeutics Raises USD2.7 Million in Venture Financing 10
nLife Therapeutics Raises US$6.6 Million In Venture Financing 11
nLife Therapeutics Enters into Research Agreement with WAVE Life Sciences 12
Chemotargets Enters Into Drug Discovery Agreement With nLife Therapeutics 13
nLife Therapeutics SL, Key Competitors 14
nLife Therapeutics SL, Key Employees 15
nLife Therapeutics SL, Other Locations 16

★海外企業調査レポート[nLife Therapeutics SL-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Evonik Industries AG:企業の戦略・SWOT・財務情報
    Evonik Industries AG - Strategy, SWOT and Corporate Finance Report Summary Evonik Industries AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Arkle Resources Plc
    Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report Summary Arkle Resources Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Huber+Suhner AG (HUBN):企業の財務・戦略的SWOT分析
    Huber+Suhner AG (HUBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • InFlectis BioScience:製薬・医療:M&Aディール及び事業提携情報
    Summary InFlectis BioScience (InFlectis) is a drug discovery company that identifies and develops small molecule drugs that target the unfolded protein response to treat misfolding protein disorders such as age-related and neurodegenerative diseases. The company’s pipeline products include IFB-088, …
  • Principia Biopharma Inc (PRNB):製薬・医療:M&Aディール及び事業提携情報
    Summary Principia Biopharma Inc (Principia Biopharma) is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies for immune disorders and cancer. The company, through its proprietary Tailored Covalency platform, develops a portfolio of drug candidates …
  • Qualicaps Inc:企業の戦略的SWOT分析
    Qualicaps Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • NIIT Ltd (NIITLTD):企業の財務・戦略的SWOT分析
    NIIT Ltd (NIITLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Infinity Pharmaceuticals Inc (INFI):企業の財務・戦略的SWOT分析
    Infinity Pharmaceuticals Inc (INFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • TechnologyOne Ltd (TNE):企業の財務・戦略的SWOT分析
    TechnologyOne Ltd (TNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Whiting Petroleum Corp (WLL):企業の財務・戦略的SWOT分析
    Whiting Petroleum Corp (WLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Mammoth Energy Services Inc (TUSK):企業の財務・戦略的SWOT分析
    Mammoth Energy Services Inc (TUSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Bionik Laboratories Corp (BNKL):医療機器:M&Aディール及び事業提携情報
    Summary Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company provides rehabilitation technology that senses patient movements and limitations. It provides lower body …
  • Liberty International Holdings Inc:企業の戦略・SWOT・財務情報
    Liberty International Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Liberty International Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Universiteit Utrecht-製薬・医療分野:企業M&A・提携分析
    Summary Universiteit Utrecht (Universiteit Utrecht) is a research university that offers education programs. The university offers bachelors, master's, honor education, education for professionals, online education, training and other education courses. Its research areas include earth and sustainab …
  • Kaneka Corp (4118):企業の財務・戦略的SWOT分析
    Kaneka Corp (4118) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Swedbank AB:企業の戦略・SWOT・財務情報
    Swedbank AB - Strategy, SWOT and Corporate Finance Report Summary Swedbank AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Sihayo Gold Ltd:企業の戦略・SWOT・財務情報
    Sihayo Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Sihayo Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • SK Hynix Inc.:企業の戦略・SWOT・財務情報
    SK Hynix Inc. - Strategy, SWOT and Corporate Finance Report Summary SK Hynix Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Aslan Pharmaceuticals Pte Ltd:企業のM&A・事業提携・投資動向
    Aslan Pharmaceuticals Pte Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aslan Pharmaceuticals Pte Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Antilles Oil and Gas NL (AVD):石油・ガス:M&Aディール及び事業提携情報
    Summary Antilles Oil and Gas NL (Antilles) is an upstream oil and gas company that carries out the acquisition and exploration of petroleum and gas properties. The company acquires underperforming assets and re-evaluates to identify untapped recoverable reserves. The company’s operates an exploratio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆